Ability to Drive of Early Stage Alzheimer Disease
DRIVE COG
1 other identifier
interventional
60
1 country
1
Brief Summary
The main objectives of this study are:
- To evaluate the driving capacities in a population of elderly subjects with early stage Alzheimer Disease (AD) in a real-life situation.
- Define a typology of the main errors made in this population.
- Propose adaptive measures or technological aids that would make it possible for these patients to maintain their ability to drive a car while limiting risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable alzheimer-disease
Started Jul 2012
Typical duration for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2012
CompletedFirst Posted
Study publicly available on registry
March 29, 2012
CompletedStudy Start
First participant enrolled
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedNovember 26, 2025
June 1, 2016
March 27, 2012
November 21, 2025
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- The following subjects will be included and classified as " patients " :
- Age \> 70 years
- With established diagnosis of Alzheimer's disease as defined by DSM IV
- With MMSE score ≥ 24 (early-stage Alzheimer's disease)
- Holder of a valid driving license
- With regular driving activity (drives at least once per week)
- Informed consent provided.
- The following subjects will be included and classified as " controls " :
- Age \> 70 years,
- Absence of cognitive impaired that interferes with their daily life at initial evaluation,
- Holder of a valid driving license,
- With regular driving activity (drives at least once per week),
- Informed consent provided.
You may not qualify if:
- Dementia syndrome(s) other than Alzheimer's disease,
- MMSE score \< 24
- Informed consent not provide
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
CHU de REIMS
Reims, France, 51092, France
Related Publications (1)
Paire-Ficout L, Lafont S, Conte F, Coquillat A, Fabrigoule C, Ankri J, Blanc F, Gabel C, Novella JL, Morrone I, Mahmoudi R. Naturalistic Driving Study Investigating Self-Regulation Behavior in Early Alzheimer's Disease: A Pilot Study. J Alzheimers Dis. 2018;63(4):1499-1508. doi: 10.3233/JAD-171031.
PMID: 29782312BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
JEAN-LUC NOVELLA, MD PhD
CHU de Reims
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2012
First Posted
March 29, 2012
Study Start
July 1, 2012
Study Completion
July 1, 2015
Last Updated
November 26, 2025
Record last verified: 2016-06